Drug repositioning: identifying and developing new uses for existing drugs

Keywords

Biopharmaceutical, Drug repositioning, Business, Productivity, Drug discovery

References

• Dark Remedy: The Impact of Thalidomide and Its Revival as a Vital MedicineKenneth C. Anderson — 2001
• Dark Remedy: The Impact of Thalidomide and Its Revival as a Vital MedicineTrent D. Stephens, Rock Brynner — 2000
• A guide to drug discovery: Trends in development and approval times for new therapeutics in the United StatesJanice M. Reichert — 2003
• Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat.Karl B. Thor, Mary A. Katofiasc — 1995
• Polyamine metabolism: a potential therapeutic target in trypanosomes.Carol Bacchi, Henry C. Nathan, S. H. Hutner — 1980
• Thalidomide is an inhibitor of angiogenesis.Robert J. D’Amato, Michael Loughnan, Evelyn Flynn — 1994
• Erectile-dysfunction therapiesR Renaud, Hayley Xuereb — 2002
• Moving beyond the genome projectsGlenn A. Friedrich — 1996
• Sexual dysfunction in the United States: prevalence and predictors.Edward O. Laumann, Anthony Paik, Raymond C. Rosen — 1999
• Business Week OnlineDavid A. Flynn — 2005
• The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.Raymond C. Rosen, Alan Riley, Gorm Wagner — 1997
• Duloxetine versus placebo in the treatment of stress urinary incontinence.Peggy Norton, Norman R. Zinner, Ilker Yalcin — 2002
• Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy.Anthony E. Pegg — 1988
• Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytesE P Sampaio, Euzenir Nunes Sarno, Ruth Galilly — 1991
• Three-Way Street: Strategic Reciprocity in World PoliticsJohn R. Freeman, Joshua S. Goldstein — 1990
• New ways to take old drugs.G. Miller — 1998
• Colonizing therapeutic space: the overlooked science of drug husbandry2004
• Rebuilding Big Pharma ’ s Business ModelJames L. Gilbert, Preston Henske, Ashish Singh
• Realism in drug discovery—could Cassandra be right?D. Horrobin — 2001

Cited by

• A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use caseHaley A. Andreozzi — 2015
• N-acetylcysteine prevents stress-induced anxiety behavior in zebrafish.Amelia Sánchez Gómez — 2015
• Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation裕一 福留, 登 藤本, 清 中川 — 2015
• Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse EventsGaetano Antonio Lanza, Mariano Strano, Marion Calandra — 2016
• Konzepterkennung in InformationsnetzwerkenT. Kötter — 2012
• Virtual screening and experimental validation identify novel modulators of nuclear receptor RXRα from Drugbank database.徐猛, 李新营 — 2017
• A bibliometric review of drug repurposing裕朗 郡司, 勇一郎 岩崎, 義孝 石井 — 2018
• Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)Kazi Rasel Uddin, Jarosław Kita, H. Hiraoka — 2018
• Drug Repurposing in Parkinson’s Disease和俊 平田, 邦壽 武居 — 2018
• Role of Overexpressed Transcription Factor FOXO1 in Fatal Cardiovascular Septal Defects in Patau Syndrome: Molecular and Therapeutic StrategiesBernat Bou Oliver — 2018
• Multilayer architecture microfluidic network array for combinatorial drug testing on 3D-cultured cells保博 深谷, 明彦 生田, 剛士 山田 — 2019
• Drug repositioning using disease associated biological processes and network analysis of drug targets.Sachin Mathur, Deendayal Dinakarpandian — 2011
• The role of Hsp20 in Alzheimer's diseaseRyan T. Cameron — 2014
• Systems biology approaches and tools for analysis of interactomes and multi-target drugs.André Schrattenholz, Karlfried Groebe, Vukić Šoškić — 2010
• The Current State of Drug Discovery and a Potential Role for NMR MetabolomicsRobert Powers — 2014
• Use and Development of Computational Tools in Drug Discovery: From Small Molecules to Cyclic PeptidesDaniel N. Santiago — 2012
• NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ARE ANTI-INFLAMMATORY AND TARGET DRY AGE-RELATED MACULAR DEGENERATIONB. Fowler — 2014
• Diseño de fármacos asistido por computadoraFabián López Vallejo, José Luis Medina Franco, Rafael Castillo — 2018
• In vitro Tissue Engineering of Liver and Primary Lymphoid Tissues with Inverted Colloidal Crystal Scaffolds for Drug Testing Application.Jung Woo Lee — 2009
• [Does cannabis use lead to schizophrenia?].Karsten Heekeren — 2011

Related papers

• Facts, Fiction, and the Pharmaceutical IndustryJohn Lloyd Hanson — 1986
• Voluntary control of drug promotion in Sweden.E Perman — 1990
• Excess in the pharmaceutical industryMarcia Angell — 2004
• The pharmaceutical industry as a political player.John Abraham — 2002
• [Physicians and drug industry: attitudes and practice].Olaf Gjerløw Aasland, Rei­dun Før­de — 2004
• Gifts to physicians from industry.Keith Bauer — 2000
• Does family medicine have a professional obligation to play a leading role in pharmaceutical industry-sponsored drug research?: yes.Anthony D’Urzo — 2011